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Abstract
Background—Trends in cardiovascular mortality across Europe demonstrate significant 
geographical variation and an understanding of these has a central role in global public health. 
Methods and Results—Ischaemic heart disease (IHD) and cerebrovascular disease (CVD) age 
standardised death rates (as per International Classification of Diseases ninth/ tenth editions) 
were collated from the World Health Organisation mortality database, for member states of the 
European Union. Trends were characterised by using Joinpoint regression analysis. An overall 
trend for reduction in IHD mortality is observed, most pronounced in Western Europe (greater 
than 60% for Netherlands, United Kingdom, Ireland) for both sexes 1980-2009. Eastern-
European states – Romania, Croatia and Slovakia had very modest mortality reductions. Most 
recently (2009), Lithuania had the highest mortality for males and females (318.1/100,000 and 
166.1/100,000 respectively), followed by Latvia and Slovakia. France had the lowest mortality - 
39.8/100,000 for males and 14.7/100,000 for females. Analysis of CVD mortality revealed that 
Austria had the largest reduction for both sexes (76.8% males, 76.5% females) 1980-2009. The 
smallest improvement over this period is seen in Lithuania, Poland and Cyprus (-5% to +20% 
approximately). France has the lowest present-day CVD mortality for both males and females 
(23.9/100,000 and 17.3/100,000 respectively). 
Conclusions—There is growing disparity in cardiovascular mortality between Western and 
Eastern Europe, for which diverse explanations are discussed. The need for population-wide 
health promotion and primary prevention policies are emphasized. 
 
Key words: epidemiology; cardiovascular disease; cerebrovascular disorders 
 at Imperial College London Library on April 11, 2016http://circ.ahajournals.org/Downloaded from 
DOI: 10.1161/CIRCULATIONAHA.115.018931 
3 
Introduction 
Cardiovascular disease is the leading cause of mortality worldwide1 and trends in cardiovascular 
mortality have a crucial role in public health and epidemiology globally. This is an area of 
academic interest, and of great geographical variation.2,3,4 
Analysis of cardiovascular mortality data relating to the Americas has demonstrated an 
inequality between the US and Canada, and Latin American nations, in age-standardised decline 
in cardiovascular mortality.5 Previous studies on trends in Europe have highlighted a similar 
health gap between Western countries and Eastern, previously Communist-run, states.2-4,6-8 
Moreover, a North-East to South-West Europe gradient was identified in the 1980s.6 Various 
hypotheses have been generated for this disparity, including lifestyle factors, diet and 
socioeconomic influences.7 
No recent analysis comparing trends in cardiovascular mortality throughout Europe has 
been performed. The objective of this study was to describe current mortality rates for ischaemic 
heart disease (IHD) and cerebrovascular disease (CVD) across Europe. We also aimed to 
describe changes in IHD and CVD mortality between 1980-2009 and identify trends using 
Joinpoint analysis. 
 
Methods
Data Sources 
Mortality data for CVD and IHD for European countries were derived from the World Health 
Organisation (WHO) mortality database for the years 1980-2009.9 The WHO evaluates the 
quality of the data to ensure comparability and reliability, without adjustment for under-
reporting.10 Member states of the European Union (EU) (28 countries as of 2015) were selected 
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to produce a defined group for analysis.11 For simplicity and clarity mortality was restricted to 
that of CVD and IHD, excluding mortality from other cardiovascular causes. The mortality 
database is updated annually from deaths registered by national civil registration systems, 
International Classification of Diseases (ICD) coded, per 100,000 population. Data is collected 
according to ICD 9 and 10 publications, and is collated as per the 10th revision; a process which 
has been utilised previously with adequate validity and data robustness.5 ICD codes were utilised 
for CVD mortality (430-438, I60-I69) and IHD mortality (410-414, I20-I25) for the 9th and 10th 
editions respectively. 
The age-standardised death rate (ASDR) was calculated, defined as mortality weighted to 
the distribution of mortality per 5-year age group, according to the WHO standard population 
and world average age structure for 1998. This removes effects of historical events on age 
structure and controls for differences in age structure in populations, producing age-specific 
mortality rates, and more representative data.12 
Estimated level of coverage for deaths with a recorded cause for death is calculated by 
actual reporting divided by estimated mortality rate. Population and birth recording in all 
countries exceeds 90%, as per the WHO standard for inclusion in the database.13 Mortality data 
were missing in a small subset of countries for one or more calendar years. When values were 
not available, data from previous or subsequent years were replicated in a last observation 
carried forward method. A total of 4.7% of data were replicated from last and subsequent 
observations. Gender-specific trends in cardiovascular mortality are established and analysed for 
three-year periods every decade; in 1.1% averages were from two-year rather than three-year 
periods. 
Statistical Analyses 
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Joinpoint regression analysis with annualised data (between 1979-2009, where available) was 
used to assess changes in linear slope for mortality trends over time,14 as described previously by 
Rodriguez et al.5 Briefly, Joinpoint analysis assesses the overall trends in mortality initially with 
no Joinpoints and tests for significant changes in the model with sequential addition of points 
where there is significant change in the slope of the line. Statistical trends were assessed using 
Joinpoint software (Version 4.1.1.1) provided by the United States National Cancer Institute 
Surveillance Research Program (http://surveillance.cancer.gov/joinpoint/). The model also 
computes an estimated annual percentage change (EAPC) for each trend by fitting a regression 
line to the natural logarithm of the rates. 
Trends in IHD and CVD mortality are calculated as crude absolute differences between 
averaged 3-year data points for the earliest and most recent years available. 
Differences in change in mortality between new EU-states and their older counterparts 
1980-2009 were assessed with Wilcoxon rank-sum test. EU joining nations from 2004 or later 
were deemed ‘new’ – such countries include Bulgaria, Croatia, Czech Republic, Estonia, 
Hungary, Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia.11 Of note, Cyprus was 
excluded from this analysis owing to significantly outlying results based on few data points. 
Post-Hoc Investigation 
From the above a priori Joinpoint analyses, we observed a common trend in the decrease in 
mortality from IHD in the years following end of Communism. We performed a single post-hoc 
analysis to explore the overall effect that the end of Communism has on age-standardised death 
rates from IHD. For this investigation, all Communist countries were normalized to the year of 
the end of Communism, which is taken to be the reference year for trend analysis. We fitted a 
locally weighted scatterplot smoothing (LOWESS) line to age-standardised death rates in the 
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interval from 10 years prior to reference year until 20 years after the reference year. LOWESS 
regression is a standard non-parametric smoothing procedure which makes minimal assumptions 
about the data and corrects for the influence of outliers from the trend to obtain a more robust 
trend estimate. Plots with 95% confidence bands from this analysis were inspected visually to 
ascertain trends in the data. LOWESS regression analysis was performed using SAS software 
v9.4 (SAS Institute, Cary, NC, USA).  
Results 
Over the 30-year period studied, significant changes in cardiovascular mortality were observed 
across the EU. All countries have an estimated level of coverage of deaths that are registered 
with cause of death data of >95%, with the exception of Cyprus (>78.2%) and Croatia (>94.9%) 
(WHO, Census and civil registration coverage data by country, 2014). The quality and 
robustness of the data collected has been reviewed previously.15 Of the 28 countries included in 
the analysis 24 had quality of reporting graded as ‘High’ or ‘Medium’. A total of four of the 
countries (Cyprus, Greece, Poland, Portugal), assessed in this analysis were graded to have 
‘Low’ reporting. Values were replicated from last and subsequent observations in 4.7% of data 
points, owing to incomplete reporting. 
There was a statistically significant greater mortality reduction for both IHD (p<0.01) and 
CVD (p<0.01) when comparing older, and newer (2004 or later) EU countries. This is displayed 
in Figure 1 A and B, for IHD and CVD respectively. 
Trends in IHD Mortality 
Figure 2 and Supplement Table 1 show IHD mortality from 1980-2009 for each country per 
gender. No data were available for EU member states Malta and Luxembourg on the WHO 
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mortality database, so have been omitted from further analysis. 
The overall trend in IHD mortality across Europe was observed to be decreasing steadily 
over time. Western European countries and founder EU member states show the greatest 
reduction in mortality (Figure 2). The largest decrease was seen in the Netherlands (73.8% 
males, 72.0% females) and United Kingdom (67.3% males, 65.9% females) from 1980-2009. 
Very modest reductions in mortality were observed in previous member states of the Soviet 
Union and Eastern Europe 1980-2009, such as Lithuania (-13.1%, -30.4%), Poland (-14.4%, 
+16.1%), Hungary (-13.1%, -1.9%) and Slovakia (-7.0%, +4.8%) for males and females 
respectively. Furthermore, unfavourable trends in IHD mortality were observed from 1980-2009 
in Croatia (+43.3%, +124.5%), Cyprus (+418.3%, +320.1%) and Romania (+30.2%, +14.8%) for 
males and females respectively. It should be noted that the IHD mortality figures for Cyprus 
(+418.3% for males and +320.1% for females) are based on only two time points with low 
mortality rates, adding ambiguity to the interpretation of these data.  
Current IHD Mortality 
Figure 3 A and B depict age-standardised death from IHD per 100,000 males and females 
respectively in 2009, to provide the most recent overview of mortality rate in EU member states. 
However, for Denmark and Belgium 2006 data was utilised, and 2008 data for France and Italy; 
these being the most recent figures available. Lithuania had the highest IHD mortality for both 
males and females (318.1/100,000 and 166.1/100,000 respectively). France had the lowest 
mortality for both males (39.8/100,000) and females (14.7/100,000). There is significant 
disparity between EU member states with the highest and lowest IHD mortalities (France and 
Lithuania, for 2008 and 2009 respectively) – approximately eight-fold for males and 11-fold for 
females. 
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Trends in CVD Mortality 
Figure 4 and Supplement Table 2 display CVD mortality from 1980-2009 for both males and 
females. Overall, there was a significant reduction in mortality across Europe; with Austria 
having the largest reduction for both sexes (76.8% males, 76.5% females). Western countries 
exhibit faster declining trends in mortality from CVD than IHD, with the exception of Denmark, 
Sweden and Netherlands. Over the 30-year period for males the least improvement is seen in 
Slovakia (-4.3%), whilst Romania (+7.4%), Lithuania (+13.7%), Cyprus (+14.4%) and Poland 
(+16.6%) all report an increase in male CVD mortality. Similarly, for females, Lithuania (-5.4%) 
and Poland (-4.5%) report the smallest improvements, with Cyprus (+23.6%) having increasing 
CVD mortality over the study period. 
Using the 17 countries (Austria, Belgium, Bulgaria, Estonia, France, Greece, Hungary, 
Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Spain and United 
Kingdom) with available mortality data for 1980-82, all, with the exception of Portugal, 
demonstrated a smaller gender gap with CVD than IHD mortality (average difference 
19.4/100,000 versus 103.7/100,000 respectively). This gender disparity reduced over the course 
of the study period, with a reduction of 18.1% for CVD and 36.1% for IHD mortality from 1980-
82 to 2007-09. 
Current CVD Mortality 
Figure 3 C and D display the most recent calendar year data (2009) for CVD mortality, again 
substituting 2006 for Belgium and Denmark, and 2008 for France and Italy. For both genders, 
Bulgaria (154.2/100,000 for males, 112.7/100,000 for females), Romania (146.4/100,000 for 
males, 111.3/100,00 for females) and Latvia (121.3/100,000 for males, 84.8/100,000 for females) 
had the greatest ASDR. As with IHD mortality, France had the lowest CVD ASDR for both 
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males and females (23.9/100,000 and 17.3/100,000, respectively). 
Joinpoint Analysis for IHD Mortality 
Tables 1 and 2 present the results of IHD mortality Joinpoint analysis for 1980-2009 for males 
and females. We report significant trend changes in the data, and the EAPC in mortality for 
periods covered by each trend. For both genders, there is a general favourable trend in IHD 
mortality across Europe, with Netherlands, Portugal, Bulgaria and the United Kingdom having 
rapidly accelerating declines at the present day. Male mortality declined at a consistent rate 
across the study period, with only 1 Joinpoint in Denmark, Finland, Sweden and Slovakia. 
Mortality rates in Denmark, Latvia and Sweden also declined at a steady rate in females. 
Slovakia demonstrated increasing mortality rates in females with a single Joinpoint. Initial 
increased mortality trends followed by a subsequent reduction were seen for Bulgaria and Greece 
for both genders. Very variable trends with 3 or 4 Joinpoints, fluctuating between increasing and 
decreasing mortality rates, were seen in the Eastern-European countries of Croatia, Lithuania and 
Poland for males and females. Similar inconsistent trends were also reported for Slovenia, 
Poland, Latvia and Austria for males, and Romania for females. 
Joinpoint Analysis for CVD Mortality 
Tables 3 and 4 display similar data for CVD mortality. There is an overall downward CVD 
mortality trend, with the notable exceptions of Slovakia and Slovenia which have rapid 
increasing mortality for both genders. The most recent data for Ireland revealed a modest 
increase in male mortality, and slowing decline in female mortality. Initial increasing mortality 
followed by favourable trends were seen with Lithuania, Poland and Romania for both sexes, 
whilst Belgium and Estonia demonstrated this trend in males only. Mortality reductions at 
consistent rates, with a single Joinpoint, are seen with Bulgaria and Spain for males, and 
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Bulgaria and Finland for females. Precipitous declining mortality for both sexes is observed in 
Portugal and Estonia, after an initial small increase for male mortality in Estonia 1981-1994. 
Croatia had significantly fluctuating mortality, with multiple Joinpoints for males and females. In 
the United Kingdom there was a plateau, and even moderate increase in male mortality, around 
2000. Denmark also experienced an increase male mortality, and levelling-out of female 
mortality, over the same time period. Both countries then resume mortality decline for males and 
females at a faster rate.  
Smoothed Regression Fit for Former-Communist Countries 
Figure 5 displays the LOWESS line of best fit with 95% confidence limits, using data for all of 
the previously Communist countries now in the EU. ‘Time 0’ represents the point of 
Communism ending in each of the constituent countries, with transition to Capitalist rule. The 
final 10 years of Communism, that is years -10 to 0 in Figure 5, has little change in IHD 
mortality. Mortality decline ensues 5-years after the end of Communist-rule. 
 
Discussion
This study of 30-year cardiovascular mortality trends across Europe identifies significant 
mortality decline throughout the majority of EU member states. There is however an observed 
East-West disparity for both IHD and CVD. For IHD the United Kingdom and Netherlands have 
made the greatest improvements, with France having the current lowest mortality for both males 
and females. The smallest improvements were found in Lithuania, Hungary and Slovakia, 
relatively new EU states. Austria has the largest reduction in CVD mortality, and France again 
has the lowest present day mortality. Bulgaria, Romania and Latvia have small reductions, and 
current greatest, CVD mortality.  
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An East-West cardiovascular disease inequality across Europe has been previously 
recognised.2-4,6-8 Although mortality overall is decreasing across the continent, this East-West 
gap appears to be widening. Furthermore, the impact of the transition from Communism can be 
appreciated. This suggests that there is no reduction in IHD mortality leading up to, and for 
approximately 5-years following the decline of Communism. One potential explanation for this 
is the turmoil associated with the changing of political landscapes. Once Capitalist regimes are in 
place, a decreasing IHD mortality trend ensues. 
An unexpected finding is the impressive CVD mortality reduction in Austria over the 
time period studied; no such dramatic reduction is seen with IHD, indicating the presence of 
CVD-specific factors. Hypertension is a plausible underlying factor, given its key involvement in 
stroke pathophysiology.16 The Austrian Heart Fund ran a campaign of hypertension awareness in 
1978, the fruits of which could be being reaped long term. A high level of awareness of the risks 
of hypertension amongst the Austrian population has been demonstrated, although this appears to 
have waned recently.17,18 Another factor could be the unregulated access to all levels of 
healthcare and free-provider choice delivered by the Austrian health service.19 The Austrian 
acute stroke service is also efficient with fast admissions, good availability of investigation 
modalities and few delays.20 Conversely, Bulgaria has the highest CVD mortality for both 
genders, but relatively low IHD mortality, possibly related to the prevalence of heavy alcohol use 
in the country.21 
Lithuania has the present day highest rate of IHD mortality for both sexes, although there 
is a decreasing trend for mortality in this study. A cross-sectional study of middle-aged males in 
Lithuania and Sweden recognised that traditional risk factors may not be entirely responsible. 
Dietary antioxidants and the resistance of low-density lipoproteins to oxidation was found to 
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differ between the two groups.22 A prospective study found that a low-risk cardiovascular profile 
was present in only 1% of middle-aged urban adults in Kaunas, Lithuania (1994 to 2010), with a 
worsening trend in body mass index, fasting glucose and healthy diet.23 
Cyprus has very few mortality figures recorded on the WHO database. The little data 
available, however, shows substantial increases in both CVD and IHD, with the exception of 
female CVD mortality, which demonstrates declining death rates. Conceivable reasons for this 
comprise the effects of war, erroneous and episodic health data recording, as well as the effect of 
a small population size. 
Various hypotheses have been postulated for the disparity in European cardiovascular 
disease mortality, ranging from the prevalence of socioeconomic inequality, differing diets, 
proportional health budget expenditure and access to healthcare. Rising levels of smoking, 
alcoholism, as well as poor diet and exercise participation were recorded in Russia after the 
Communist decline.24 Using Russia as a post-socialist model, several legislative factors have 
been faced in health improvement, including lack of formal health policy, scanty health 
promotion and the absence of epidemiological surveillance systems.25 The trend of IHD 
mortality has been examined in Germany 10-years after reunification, and demonstrated a clear 
East-West gradient with mortality approximately 50% greater in former-Communist East 
Germany.26 This study found differences in classical cardiovascular risk factors (high 
cholesterol, hypertension, obesity, diabetes) as well as lifestyle factors (smoking, levels of 
exercise and diet) between East and West Germany.  
The Eastern EU members have lower gross domestic product (GDP) per-capita than their 
Western counterparts; with resultant lower socioeconomic class, shorter life expectancy and 
lower healthcare expenditure.27-29 Nonetheless, Eastern European countries have greater 
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mortality than levels of wealth would predict.30 All-cause mortality has been found to be 
inversely proportional to educational attainment.31 Furthermore, education is inversely related to 
blood pressure, smoking and obesity, and correlated to health knowledge and physical activity.32 
Smoking is more prevalent in Eastern European countries, and is thought to be a considerable 
causal factor in cardiovascular health inequalities.33,34 Moreover, EU smoke-free legislation in 
public places has further reduced mortality and hospital admissions, a regulation not imposed 
stringently in many ex-socialist countries.35-37 
Although not the focus of this study, there is observed narrowing of gender inequalities in 
cardiovascular mortality, in keeping with a previous WHO report.38 This WHO paper notes that 
not only is the gap closing, but also is smaller still when healthy life expectancy is considered. 
There are many potential contributory factors for this trend, and the role of behavioural factors – 
smoking prevalence in particular – may be crucial. Male smoking rates have peaked and are 
declining in many countries across Europe, whereas female smoking rates are increasing, both 
for daily smokers and current smokers.39 Additionally, females may be more sensitive to the 
harmful effects of cigarette smoking, perhaps related to hormonal factors.40  
This study follows a heterogeneous group of countries temporally, allowing the 
observation of significant mortality developments over a 30-year period. With any 
epidemiological dataset as vast and diverse as the WHO database, issues of data reliability and 
accuracy of recording arise. There is reliance on retrospective data collection and death 
certification, and the robustness of this data needs to be considered. A potential contributing 
factor to the results of this study include the variation in assignment of causes of death, between 
and within countries, which may fluctuate with changing coding practices over time. 
Nevertheless, the WHO scrutinises death certification data for accurate levels of reporting, and 
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all the countries included in this analysis had satisfactory coverage. Conversely, Mathers et al. 
find that four countries in this study had ‘Low’ levels of reporting.15 Further potential loss of 
data reliability in this study arises due to changes in international death certification coding over 
the studied period (ICD-9 to ICD-10). For several time points no data were available, allowing 
for the potential of un-documented variation. As a descriptive analysis little statistical evaluation 
is carried out, and moreover, all explanations for mortality trends are speculative at present. 
Conclusions
There is a growing disparity in cardiovascular mortality between Western Europe and former-
Soviet states of Eastern Europe. Diverse fundamental explanations exist for this disparity and the 
need for population-wide health promotion and primary prevention policies are emphasized to 
ensure these differences do not expand further. 
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Clinical Perspective 
Cardiovascular disease is the leading cause of mortality worldwide and trends in cardiovascular 
mortality have a central role in public health and epidemiology globally. Previous studies on 
trends in Europe have highlighted a health inequality between Western countries and Eastern, 
previously Communist-run, states. This study provides an up-to-date analysis of age standardised 
death rates from ischaemic heart disease (IHD) and cerebrovascular disease (CVD) across 
member states of the European Union between 1980 and 2010. The effect of changing political 
ideologies is explored in previously Communist-run countries. Data is collated from the World 
Health Organisation mortality database, using International Classification of Diseases ninth and 
tenth editions, and is analysed using Joinpoint regression analysis. An overall trend for reduction 
in mortality from IHD and CVD is seen across Europe, although very modest mortality 
reductions are observed in Eastern-European states, Romania, Poland and Slovakia for example. 
Lithuania and Bulgaria have the present day highest mortality for both genders for IHD and 
CVD respectively. Conversely, significant reductions are seen in cardiovascular mortality in 
Western countries, with the lowest mortality from IHD and CVD for both males and females 
observed in France. In pooled data for former Communist-run countries, a trend for no reduction 
in IHD mortality leading up to, and for a number of years following, the decline of Communism 
is noted. Reasons for the growing East-West disparity are explored, and topics highlighted that 
may address this inequality. The need for population-wide health promotion and primary 
prevention policies are emphasized. 
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Table 1. Joinpoint analysis for male ischaemic heart disease mortality in 26 countries of the European Union, for years 1979-2009, 
where data available. 
Trend 1 Trend 2 Trend 3 Trend 4 
Years EAPC Years EAPC Years EAPC Years EAPC 
Austria 1980-1982 +3.03 1982-1998 -1.31* 1998-2009 -4.25*   
Belgium 1979-1984 -1.83* 1984-1990 -5.82* 1990-1999 -0.38   
Bulgaria 1980-1985 +5.02* 1985-1997 +0.28 1997-2005 -3.68* 2005-2009 -7.39* 
Croatia 1985-1990 -1.14 1990-1993 +25.79* 1993-2009 -1.74*   
Cyprus 1999-2009 +24.95*       
Czech Republic 1986-1992 -0.76 1992-2001 -5.78* 2001-2009 -1.16*   
Denmark 1994-2006 -6.89*       
Estonia 1981-1995 -0.72* 1995-2009 -4.27*     
Finland 1987-2009 -3.63*       
France 1979-1986 -0.12 1986-1990 -5.14* 1990-2001 -2.01* 2001-2008 -4.53* 
Germany 1990-1995 +1.06 1995-2003 -4.03* 2003-2009 -5.48*   
Greece 1979-1989 +1.32* 1989-2004 -0.72* 2004-2009 -4.73*   
Hungary 1979-1981 +6.33 1981-1994 +0.17 1994-2009 -1.07*   
Ireland 1979-1985 +0.12 1985-1998 -2.96* 1998-2005 -7.28* 2005-2009 -2.26* 
Italy 1979-2005 -2.39* 2005-2008 -5.93*     
Latvia 1980-1991 -1.48* 1991-1994 +8.81 1994-1997 -10.58 1997-2009 -1.84* 
Lithuania 1981-1994 +0.82* 1994-1999 -5.43* 1999-2005 +1.94 2005-2009 -2.99 
Netherlands 1979-1985 -1.52* 1985-1999 -3.99* 1999-2009 -7.52*   
Poland 1980-1991 +1.98* 1991-1997 -3.57* 1997-2000 +8.12 2000-2009 -4.34* 
Portugal 1980-2004 -1.74* 2005-2009 -8.44*     
Romania 1980-1996 +3.60* 1996-2009 -2.11*     
Slovakia 1992-2009 -0.66*       
Slovenia 1985-1988 -11.08* 1988-1992 +11.95* 1992-2009 -4.34*   
Spain 1980-1999 -0.73* 1999-2009 -4.00*     
Sweden 1987-2009 -4.32*       
United Kingdom 1979-1985 -1.28* 1985-1993 -2.97* 1993-2002 -4.80* 2002-2009 -6.36* 
EAPC, Estimated Annual Percentage Change 
*Significantly different from 0 (p<0.05) 
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Table 2. Joinpoint analysis for female ischaemic heart disease mortality in 26 countries of the European Union, for years 1979-2009, 
where data available. 
Trend 1 Trend 2 Trend 3 Trend 4 
Years EAPC Years EAPC Years EAPC Years EAPC 
Austria 1980-1998 -0.07 1998-2010 -3.75*     
Belgium 1979-1984 -0.65 1984-1990 -5.61* 1990-1999 -0.32   
Bulgaria 1980-1985 +5.94* 1985-1998 -0.67* 1998-2003 -4.16* 2003-2009 -8.54* 
Croatia 1985-1990 -0.27 1990-1993 +43.85* 1993-2009 -1.93*   
Cyprus 1999-2009 +22.70*       
Czech Republic 1986-1994 -1.49* 1994-2000 -6.60* 2000-2009 +0.06   
Denmark 1994-2006 -6.58*       
Estonia 1981-1985 +1.57 1985-2001 -2.67* 2001-2009 -6.35*   
Finland 1987-2002 -3.00* 2002-2009 -4.70*     
France 1979-1986 -0.27 1986-1994 -4.18* 1994-2002 -2.19* 2002-2008 -6.01* 
Germany 1990-1995 -0.12 1995-2003 -3.18* 2003-2009 -6.25*   
Greece 1979-1989 +2.70 1989-2004 -0.48 2004-2009 -6.25*   
Hungary 1979-1999 +0.71* 1999-2002 -3.50 2002-2005 +4.81 2005-2009 -4.80* 
Ireland 1979-1986 -0.29 1986-1998 -2.70* 1998-2005 -6.98* 2005-2009 -3.00* 
Italy 1979-1986 -5.33* 1986-2005 -1.57* 2005-2008 -7.01*   
Latvia 1980-2009 -2.39*       
Lithuania 1981-1988 +0.90 1988-2000 -2.82* 2000-2006 +0.30 2006-2009 -4.50 
Netherlands 1979-1996 -2.96* 1996-2002 -5.37* 2002-2009 -8.13*   
Poland 1980-1997 +0.80* 1997-2000 +13.47 2000-2009 -4.21*   
Portugal 1980-2004 -1.47* 2004-2009 -8.20*     
Romania 1980-1987 +4.66* 1987-1990 -1.36 1990-1996 +4.11* 1996-2009 -2.62* 
Slovakia 1992-2009 +0.19       
Slovenia 1985-1987 -20.23* 1987-1992 +15.79* 1992-2009 -5.84*   
Spain 1980-1998 -0.76* 1998-2005 -3.59* 2005-2009 -5.90*   
Sweden 1987-2009 -3.81*       
United Kingdom 1979-1985 -0.35 1985-1993 -2.41* 1993-2003 -4.95* 2003-2009 -7.19* 
EAPC, Estimated Annual Percentage Change 
*Significantly different from 0 (p<0.05)
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Table 3. Joinpoint analysis for male cerebrovascular disease mortality in 26 countries of the European Union, for years 1979-2009, 
where data available. 
Trend 1 Trend 2 Trend 3 Trend 4 
Years EAPC Years EAPC Years EAPC Years EAPC 
Austria 1980-2002 -4.38* 2002-2005 -14.03* 2005-2009 -3.56   
Belgium 1979-1983 +0.17 1983-1987 -7.04* 1987-2003 -2.60* 2003-2006 -8.27* 
Bulgaria 1980-2009 -0.92*       
Croatia 1985-1994 -1.27* 1994-1999 +3.41 1999-2002 -9.08 2002-2009 -3.14* 
Cyprus 1999-2009 +2.71       
Czech Republic 1986-1990 -2.10 1990-1997 -6.00* 1997-2003 -1.04 2003-2009 -9.00* 
Denmark 1994-2000 -2.67* 2000-2003 +2.67 2003-2006 -7.10*   
Estonia 1981-1994 +0.17 1994-2006 -4.42* 2006-2009 -17.25*   
Finland 1987-1993 -1.82* 1993-2009 -4.33*     
France 1979-1986 -3.36* 1986-1989 -9.63* 1989-2002 -3.40* 2002-2008 -5.21* 
Germany 1990-1995 -2.16* 1995-2009 -6.00*     
Greece 1979-2002 -1.19* 2002-2009 -5.99*     
Hungary 1979-2003 -1.58* 2003-2006 -10.07* 2006-2009 -2.37   
Ireland 1979-2001 -3.46* 2001-2006 -7.86* 2006-2009 +0.38   
Italy 1979-1985 -1.13 1985-2008 -3.86*     
Latvia 1980-1991 -0.20 1991-1994 +3.63 1994-2005 -2.66* 2005-2009 -7.52* 
Lithuania 1981-1993 +1.13* 1993-2009 -0.07     
Netherlands 1979-1987 -2.79* 1987-1991 -0.28 1991-2002 -2.32* 2002-2009 -7.16* 
Poland 1980-1997 +1.28* 1997-2000 +9.21 2000-2009 -3.74*   
Portugal 1980-1996 -2.66* 1996-2009 -6.38*     
Romania 1980-1991 +0.71* 1991-1994 +11.05 1994-2005 -1.47* 2005-2009 -5.22* 
Slovakia 1992-2006 -1.97* 2006-2009 +9.15*     
Slovenia 1985-1992 -1.01 1992-2003 -4.54* 2003-2007 -8.54* 2007-2009 +10.57 
Spain 1980-2009 -4.31*       
Sweden 1987-1998 -0.87* 1999-2010 -4.16*     
United Kingdom 1979-2000 -3.12* 2000-2003 +0.43 2002-2009 -6.96*   
EAPC, Estimated Annual Percentage Change 
*Significantly different from 0 (p<0.05)
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Table 4. Joinpoint analysis for female cerebrovascular disease mortality in 26 countries of the European Union, for years 1979-2009, 
where data available. 
Trend 1 Trend 2 Trend 3 Trend 4 
Years EAPC Years EAPC Years EAPC Years EAPC 
Austria 1980-2002 -4.21* 2002-2005 -14.00* 2005-2009 -4.16   
Belgium 1979-1983 -0.44 1983-1987 -6.87* 1987-2004 -2.86* 2004-2006 -7.23 
Bulgaria 1980-2009 -1.46*    -   
Croatia 1985-1993 -1.91* 1993-1999 +2.63* 1999-2002 -9.11* 2002-2009 -2.86* 
Cyprus 1999-2006 -7.13* 2006-2009 -9.19     
Czech Republic 1986-1997 -4.96* 1997-2002 +0.26 2002-2009 -8.27*   
Denmark 1994-1998 -3.22* 1998-2003 -0.32 2003-2006 -4.55*   
Estonia 1981-1993 -0.63* 1993-2003 -4.36* 2003-2006 -9.31 2006-2009 -17.14* 
Finland 1987-2009 -4.25*       
France 1979-1986 -3.38* 1986-1989 -9.41* 1989-2003 -3.40* 2003-2008 -5.52* 
Germany 1990-1993 -1.29 1993-2009 -5.22*     
Greece 1979-1985 -0.43 1985-2003 -1.58* 2003-2009 -6.33*   
Hungary 1979-2003 -2.23* 2003-2006 -10.09* 2006-2009 -3.75*   
Ireland 1979-1990 -4.58* 1990-2000 -2.83* 2000-2005 -8.64* 2005-2009 -0.05 
Italy 1979-1985 -1.16 1985-2008 -3.73*     
Latvia 1980-1983 +4.34 1983-2003 -1.24* 2003-2009 -7.85*   
Lithuania 1981-1995 +0.37 1995-2009 -0.73*     
Netherlands 1979-1987 -2.90* 1987-1992 -0.18 1992-2002 -2.21* 2002-2009 -6.12* 
Poland 1980-1997 +0.54* 1997-2000 +10.60 2000-2009 -4.91*   
Portugal 1980-1999 -3.06* 1999-2009 -7.14*     
Romania 1980-1991 +0.22 1991-1994 +7.32 1994-2005 -1.53* 2005-2009 -6.28* 
Slovakia 1992-2006 -2.63* 2006-2009 +9.16     
Slovenia 1985-1993 -2.50* 1993-2003 -4.52* 2003-2006 -10.95 2006-2009 +6.99 
Spain 1980-1991 -4.23* 1991-2009 -4.95*     
Sweden 1987-2002 -1.64* 2002-2005 -7.26* 2005-2009 -2.72*   
United Kingdom 1979-2000 -3.05* 2000-2003 -0.23 2003-2009 -6.39*   
EAPC, Estimated Annual Percentage Change 
*Significantly different from 0 (p<0.05)?
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Figure Legends: 
Figure 1. Changes in age standardised death certification rates per 100 000 for countries joining 
the European Union prior to 2004 and 2004 or later, 1980-2009, for ischaemic heart disease (A) 
and cerebrovascular disease (B). Pre-2004 countries – Austria, Belgium, Denmark, Finland, 
France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden and United 
Kingdom. Post-2004 countries – Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, 
Lithuania, Poland, Romania, Slovakia and Slovenia. * represents statistical significance at 
p<0.01. 
Figure 2. Trends in age standardised death certification rates per 100 000 for ischaemic heart 
disease in countries joining the European Union prior to 2004 (A) and 2004 or later (B),1980–
2009.  Triangles, males; circles; females. 
Figure 3. Age standardised death certification rates per 100 000 for ischaemic heart disease 
(males (A) and females (B)) and cerebrovascular disease (males (C) and females (D)) in 26 
countries of the European Union in 2009 (2006 for Belgium and Denmark, 2008 for France and 
Italy). 
Figure 4. Trends in age standardised death certification rates per 100 000 for cerebrovascular 
disease in countries joining the European Union prior to 2004 (A) and 2004 or later (B), 1980–
2009. Triangles, males; circles; females. 
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Figure 5. Locally weighted scatterplot smoothing (LOWESS) fit of age-standardised death 
certification rates per 100 000 for ischaemic heart disease, for individual former Communist 
countries now in the European Union. Year 0 represents the end of Communist rule. 95% 
confidence limits for the line of best fit are shown.  
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Austria 182.3 167.7 139.6   99.5  -45.4 
 
  78.8   81.0   71.5   53.3  -32.3 
 
Belgium* 145.0   96.9   92.5   72.4  -50.1* 
 
  60.8   42.6   40.7   31.7  -47.8* 
 
Bulgaria 177.0 215.0 189.8 131.2  -25.9 
 
110.4 132.9 111.8   65.0  -41.1 
 
Croatia x 110.0 181.6 150.6   43.3* 
 
x   46.4 104.2   88.2 124.5* 
 
Cyprus* x x   16.4   85.0 418.3* 
 
x x     7.8   32.8 320.1* 
 
Czech 
Republic 
x 319.0 194.0 168.8  -48.7* 
 
x 161.8 102.9 100.8  -41.6* 
 
Denmark* x x 118.3   80.1  -53.8* 
 
x x   59.7   39.9  -52.2* 
 
Estonia* 484.7 443.0 362.2 242.3  -50.0* 
 
269.0 242.3 184.7 116.4  -56.7* 
 
Finland x 266.1 188.2 136.8  -53.0* 
 
x 116.3   86.4   61.7  -50.8* 
 
France*   84.7   69.9   56.1   41.2  -51.4* 
 
  35.8   29.4   21.9   15.3  -57.3* 
 
Germany* x 171.1 133.2   89.2  -47.9* 
 
x   81.3   68.2   45.3  -44.3* 
 
Greece   92.4 103.0   94.7   76.5  -17.2 
 
  34.8   44.2   41.3   31.9    -8.3 
 
Hungary 253.5 253.3 241.1 220.2  -13.1 
 
125.4 127.3 134.4 123.0    -1.9 
 
Ireland 294.6 255.4 174.0 112.2  -61.9 
 
135.1 118.8   82.5   53.0  -60.7 
 
Italy* 129.9 103.1   79.7   63.9  -50.8* 
 
  62.7   46.8   38.2   31.5  -49.8* 
 
Latvia 455.5 401.9 346.6 304.3  -33.2 
 
255.3 212.4 168.3 140.6  -44.9 
 
Lithuania* 383.1 410.7 328.8 333.0  -13.1* 
 
250.6 245.3 182.7 174.4  -30.4* 
 
Luxembourg x x x x  x 
 
x x x x  X 
 
Malta x x x x  x 
 
x x x x  X 
 
Netherlands 193.6 146.9   94.6   50.7  -73.8 
 
  80.8   60.9   41.5   22.6  -72.0 
 
Poland 128.4 152.3 154.2 109.9  -14.4 
 
  43.4   49.6   70.6   50.4   16.1 
 
Portugal   91.1   85.4   65.6   45.3  -50.3 
 
  45.9   42.5   33.2   23.5  -48.9 
 
Romania 142.9 184.8 219.2 186.0   30.2 
 
  97.6 125.8 141.9 112.0   14.8 
 
Slovakia* x 276.1 269.7 256.7   -7.0* 
 
x 152.6 167.1 159.8    4.8* 
 
Slovenia x 120.7 114.9   73.3  -48.2* 
 
x   65.7   54.5   31.2  -53.3* 
 
Spain   87.0   80.9   72.7   52.6  -39.5 
 
  37.8   35.4   30.7   21.6  -42.9 
 
Sweden x 199.4 132.6   91.1  -61.1* 
 
x   87.6   61.4   44.0  -55.8* 
 
United 
Kingdom 
283.9 233.0 151.3   93.0  -67.3   123.1 109.2   70.3   42.0  -65.9 
 
Supplement Table 1. Three-year average trends in age standardised death certification rates per 100 000 for ischaemic 
heart disease, 1980–2009 
 
*For Belgium 1997-99 and 2004-06 were used for 1999-2001 and 2007-09, with % change 1980-82 v 2004-06; for Croatia % change is 1985 v 2007-
09; for Cyprus there was no value for 2001, with % change 1999-2000 v 2007-09; for Czech Republic % change was 1986 v 2007-09; for Denmark 
2004-06 was used for 2007-09, with % change 1994 v 2004-06; for Estonia there was no value for 1980, with % change 1981-82 v 2007-09; for 
Finland % change was 1987 v 2007-09; for France 2006-08 was used for 2007-09, with % change 1980-82 v 2006-08; for Germany 1990-92 was 
used for 1989-91, with % change 1990-92 v 2007-09; for Italy 2006-08 was used for 2007-09, with % change 1980-82 v 2006-08; for Lithuania there 
was no value for 1980, with % change 1981-82 v 2007-09; for Slovakia 1992-94 was used for 1989-91, with % change 1992-94 v 2007-09; for 
Slovenia % change was 1985 v 2007-09; for Sweden % change was 1987 v 2007-09 
x data not available 
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Austria 125.5   84.9   56.4   29.2  -76.8 
 
  99.4   67.3   46.0   23.3  -76.5 
 
Belgium*   84.3   58.7   46.1   34.9  -58.6* 
 
  69.4   48.1   37.0   29.7  -57.2* 
 
Bulgaria 208.7 195.4 170.6 161.9  -22.4 
 
180.8 153.0 131.6 120.6  -33.3 
 
Croatia x 150.4 147.0 102.4  -32.0* 
 
x 114.5 111.9   79.0 -36.8* 
 
Cyprus* x x   25.8   29.5   14.4* 
 
x x   23.3   28.7   23.6* 
 
Czech 
Republic 
x 173.6 112.3   65.4  -66.2* 
 
x 130.2   89.6   52.5  -65.3* 
 
Denmark* x x   50.0   45.9  -17.4* 
 
x x   40.1   36.4  -20.4* 
 
Estonia* 181.5 176.1 145.9   74.2  -59.1* 
 
155.7 142.8 106.5   48.4  -68.9* 
 
Finland x   82.2   56.5   40.2  -54.4* 
 
x   66.4   43.4   29.7  -59.3* 
 
France*   82.2   49.9   34.9   24.8  -69.9* 
 
  58.2   35.8   24.8   17.6  -69.7* 
 
Germany* x   75.2   50.2   30.8  -58.5* 
 
x   59.5   39.1   25.8  -56.3* 
 
Greece 106.6   96.6   85.1   57.1  -46.4 
 
110.9 102.0   85.9   59.1  -46.7 
 
Hungary 183.0 156.8 135.9   88.5  -51.6 
 
140.4 112.8   92.2   56.8  -59.6 
 
Ireland   97.0   67.5   52.1   32.2  -66.8 
 
  92.4   60.5   45.8   29.2  -68.4 
 
Italy* 101.0   79.5   53.7   39.3  -61.1* 
 
  78.0   60.8   42.0   31.3  -59.9* 
 
Latvia 199.5 198.0 184.2 128.8  -35.4 
 
165.1 158.1 143.2   92.8  -43.8 
 
Lithuania*   92.5 101.5 100.8 105.2    13.7* 
 
  84.4   85.6   83.4   79.8    -5.4* 
 
Luxembourg x x x x  x 
 
x x x x  x 
 
Malta x x x x  x 
 
x x x x  x 
 
Netherlands   67.1   56.4   45.2   27.8  -58.6 
 
  54.9   45.5   38.4   25.0  -54.6 
 
Poland   59.1   65.6   91.5   68.9   16.6 
 
  50.1   49.6   69.5   47.9    -4.5 
 
Portugal 220.3 177.2 115.9   65.8  -70.1 
 
173.3 136.9   91.0   50.7  -70.8 
 
Romania 140.0 148.7 184.3 150.4     7.4 
 
131.3 134.1 148.7 116.8  -11.0 
 
Slovakia* x   90.5   79.0   86.6    -4.3* 
 
x   65.3   54.1   57.6  -11.7* 
 
Slovenia x 115.1   78.7   54.6  -56.9* 
 
x   81.4   54.0   38.8  -59.3* 
 
Spain 105.3   73.7   47.3   32.2  -69.4 
 
  89.9   61.8   37.8   24.7  -72.6 
 
Sweden x   55.9   47.4   33.7  -39.7* 
 
x   46.1   38.4   27.3  -41.7* 
 
United 
Kingdom 
  89.3   71.0   50.4   34.9  -60.9     79.1   62.7   45.7   32.5  -58.9 
 
Supplement Table 2. Three-year average trends in age standardised death certification rates per 100 000 for 
cerebrovascular disease, 1980–2009 
 
*For Belgium 1997-99 and 2004-06 were used for 1999-2001 and 2007-09, with % change 1980-82 v 2004-06; for Croatia % change is 1985 v 2007-
09; for Cyprus there was no value for 2001, with % change 1999-2000 v 2007-09; for Czech Republic % change was 1986 v 2007-09; for Denmark 
2004-06 was used for 2007-09, with % change 1994 v 2004-06; for Estonia there was no value for 1980, with % change 1981-82 v 2007-09; for 
Finland % change was 1987 v 2007-09; for France 2006-08 was used for 2007-09, with % change 1980-82 v 2006-08; for Germany 1990-92 was 
used for 1989-91, with % change 1990-92 v 2007-09; for Italy 2006-08 was used for 2007-09, with % change 1980-82 v 2006-08; for Lithuania there 
was no value for 1980, with % change 1981-82 v 2007-09; for Slovakia 1992-94 was used for 1989-91, with % change 1992-94 v 2007-09; for 
Slovenia % change was 1985 v 2007-09; for Sweden % change was 1987 v 2007-09 
x data not available 
 
